Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer
Abstract Exosomes are carriers of intercellular information that regulate the tumor microenvironment, and they have an essential role in drug resistance through various mechanisms such as transporting RNA molecules and proteins. Nevertheless, their effects on gemcitabine resistance in triple-negativ...
Main Authors: | Ting Li, Zhonghua Tao, Yihui Zhu, Xiaojia Liu, Leiping Wang, Yiqun Du, Jun Cao, Biyun Wang, Jian Zhang, Xichun Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-03963-7 |
Similar Items
-
Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
by: Pankaj Chaudhary, et al.
Published: (2020-01-01) -
Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies
by: Olga Y. Korolkova, et al.
Published: (2020-08-01) -
Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
by: Pankaj Chaudhary, et al.
Published: (2020-03-01) -
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
by: Jia Jin, et al.
Published: (2018-04-01) -
Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial
by: Yannan Zhao, et al.
Published: (2018-10-01)